1. 428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs). (10th December 2020) Authors: Lewis, Karl; Peris, Ketty; Sekulic, Aleksandar; Stratigos, Alexander; Dunn, Lara; Eroglu, Zeynep; Chang, Anne Lynn; Migden, Michael; Li, Siyu; Mohan, Kosalai; Coates, Ebony; Okoye, Emmanuel; Baurain, Jean-François; Bechter, Oliver; Hauschild, Axel; Butler, Marcus; Hernandez-Aya, Leonel; Licitra, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Issue 6 (June 2021) Authors: Stratigos, Alexander J; Sekulic, Aleksandar; Peris, Ketty; Bechter, Oliver; Prey, Sorilla; Kaatz, Martin; Lewis, Karl D; Basset-Seguin, Nicole; Chang, Anne Lynn S; Dalle, Stèphane; Orland, Almudena Fernandez; Licitra, Lisa; Robert, Caroline; Ulrich, Claas; Hauschild, Axel; Migden, Michael R; Dumm... Journal: Lancet oncology Issue: Volume 22:Issue 6(2021) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. How does the CHALICE rule affect CT scanning in children with head injuries?. Issue 8 (28th February 2011) Authors: Bowler, Timothy; te Water Naudé, Johann; Tuthill, David Journal: Archives of disease in childhood Issue: Volume 96:Issue 8(2011) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗